UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer

Cancer, 2018-10, Vol.124 (20), p.4010-4022

2018

Volltextzugriff (PDF)

Outcomes of localized prostate cancer following conservative management

JAMA : the journal of the American Medical Association, 2009-09, Vol.302 (11), p.1202

2009

Volltextzugriff (PDF)

Contemporary Risk Profile of Prostate Cancer in the United States

JNCI : Journal of the National Cancer Institute, 2009-09, Vol.101 (18), p.1280-1283

2009

Volltextzugriff (PDF)

Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

JAMA internal medicine, 2014-09, Vol.174 (9), p.1460

2014

Volltextzugriff (PDF)

Impact of Comorbidity on Survival Among Men With Localized Prostate Cancer

Journal of clinical oncology, 2011-04, Vol.29 (10), p.1335-1341

2011

Volltextzugriff (PDF)

Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications

BJU international, 2013-05, Vol.111 (5), p.745-752

2013

Volltextzugriff (PDF)

Patterns and Correlates of Prostate Cancer Treatment in Older Men

The American journal of medicine, 2011-03, Vol.124 (3), p.235-243

2011

Volltextzugriff (PDF)

Lifestyle, Anthropometric, and Obesity-Related Physiologic Determinants of Insulin-like Growth Factor-1 in the Third National Health and Nutrition Examination Survey (1988–1994)

Annals of epidemiology, 2010-03, Vol.20 (3), p.182-193

2010

Volltextzugriff (PDF)

Survival following primary androgen deprivation therapy among men with localized prostate cancer

JAMA : the journal of the American Medical Association, 2008-07, Vol.300 (2), p.173

2008

Volltextzugriff (PDF)

Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer

European urology, 2015-11, Vol.68 (5), p.805-811

2015

Volltextzugriff (PDF)

Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer

Cancers, 2023-04, Vol.15 (8), p.2316

2023

Volltextzugriff (PDF)

Reply to Michael Froehner, Rainer Koch, Manfred P. Wirth's Letter to the Editor re: Grace L. Lu-Yao, Peter C. Albertsen, Dirk F. Moore, Yong Lin, Robert S. DiPaola, Siu-Long Yao. Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer. Eur Urol 2015;68:805–11

European urology, 2016-06, Vol.69 (6), p.e131-e132

2016

Volltextzugriff (PDF)

Metabolic Dysregulation of the Insulin―Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971―2008)

Cancer epidemiology, biomarkers & prevention, 2013-10, Vol.22 (10), p.1825-1836

2013

Volltextzugriff (PDF)

Longitudinal Associations of Leisure-Time Physical Activity and Cancer Mortality in the Third National Health and Nutrition Examination Survey (1986-2006)

Journal of Obesity, 2012-01, Vol.2012 (2012), p.588-596

2012

Volltextzugriff (PDF)

Late Gastrointestinal Toxicities Following Radiation Therapy for Prostate Cancer

European urology, 2011-11, Vol.60 (5), p.908-916

2011

Volltextzugriff (PDF)

Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score–Matched Analysis

European urology, 2014-04, Vol.65 (4), p.693-700

2014

Volltextzugriff (PDF)

Neoadjuvant nivolumab (N) plus cisplatin (C)/pemetrexed (P) or cisplatin /gemcitabine (G) in resectable NSCLC

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9051-9051

2020

Volltextzugriff (PDF)

Severe Genitourinary Toxicity Following Radiation Therapy for Prostate Cancer—How Long Does it Last?

The Journal of urology, 2013-01, Vol.189 (1), p.116-121

2013

Volltextzugriff (PDF)

Re: Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer: A Decision Analysis

European urology, 2011-08, Vol.60 (2), p.393-393

Lu-Yao, Grace L

2011

Volltextzugriff (PDF)

Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey

Cancer causes & control, 2010-04, Vol.21 (4), p.631-642

2010

Volltextzugriff (PDF)

Obesity, Insulin Resistance, and Cancer Prognosis: Implications for Practice for Providing Care among Cancer Survivors

Journal of the American Dietetic Association, 2009-08, Vol.109 (8), p.1346-1353

2009

Volltextzugriff (PDF)

The science and art of prostate cancer screening

JNCI : Journal of the National Cancer Institute, 2011-03, Vol.103 (6), p.450-451

2011

Volltextzugriff (PDF)

Reply to Carl J. Rossi, Jr.’s Letter to the Editor re: Sung Kim, Shunhua Shen, Dirk F. Moore, et al. Late Gastrointestinal Toxicities Following Radiation Therapy for Prostate Cancer. Eur Urol 2011;60:908–16

European urology, 2012-05, Vol.61 (5), p.e44-e44

2012

Volltextzugriff (PDF)

Population-based study of long-term survival in patients with clinically localised prostate cancer

The Lancet (British edition), 1997-03, Vol.349 (9056), p.906-910

1997

Volltextzugriff (PDF)

Does Primary Androgen-Deprivation Therapy Delay the Receipt of Secondary Cancer Therapy for Localized Prostate Cancer?

European urology, 2012-12, Vol.62 (6), p.966-972

2012

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(108)

Sprache

Englisch
(108)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comparative effectiveness of radical prostatectomy with adjuvant radiotherapy versus radiotherapy plus androgen deprivation therapy for men with advanced prostate cancer

Outcomes of localized prostate cancer following conservative management

Contemporary Risk Profile of Prostate Cancer in the United States

Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer

Impact of Comorbidity on Survival Among Men With Localized Prostate Cancer

Fracture after androgen deprivation therapy among men with a high baseline risk of skeletal complications

Patterns and Correlates of Prostate Cancer Treatment in Older Men

Lifestyle, Anthropometric, and Obesity-Related Physiologic Determinants of Insulin-like Growth Factor-1 in the Third National Health and Nutrition Examination Survey (1988–1994)

Survival following primary androgen deprivation therapy among men with localized prostate cancer

Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer

Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer

Metabolic Dysregulation of the Insulin―Glucose Axis and Risk of Obesity-Related Cancers in the Framingham Heart Study-Offspring Cohort (1971―2008)

Longitudinal Associations of Leisure-Time Physical Activity and Cancer Mortality in the Third National Health and Nutrition Examination Survey (1986-2006)

Late Gastrointestinal Toxicities Following Radiation Therapy for Prostate Cancer

Cancer-specific Survival After Metastasis Following Primary Radical Prostatectomy Compared with Radiation Therapy in Prostate Cancer Patients: Results of a Population-based, Propensity Score–Matched Analysis

Neoadjuvant nivolumab (N) plus cisplatin (C)/pemetrexed (P) or cisplatin /gemcitabine (G) in resectable NSCLC

Severe Genitourinary Toxicity Following Radiation Therapy for Prostate Cancer—How Long Does it Last?

Re: Active Surveillance Compared With Initial Treatment for Men With Low-Risk Prostate Cancer: A Decision Analysis

Longitudinal associations of blood markers of insulin and glucose metabolism and cancer mortality in the third National Health and Nutrition Examination Survey

Obesity, Insulin Resistance, and Cancer Prognosis: Implications for Practice for Providing Care among Cancer Survivors

The science and art of prostate cancer screening

Reply to Carl J. Rossi, Jr.’s Letter to the Editor re: Sung Kim, Shunhua Shen, Dirk F. Moore, et al. Late Gastrointestinal Toxicities Following Radiation Therapy for Prostate Cancer. Eur Urol 2011;60:908–16

Population-based study of long-term survival in patients with clinically localised prostate cancer

Does Primary Androgen-Deprivation Therapy Delay the Receipt of Secondary Cancer Therapy for Localized Prostate Cancer?

Suchergebnisse filtern